‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner
It is fair to say that far more individuals aside from the commissioner are instrumental as far as the drug review and approval process in the U.S., but Makary we expect will promote technology and innovation in a way that offers some reprieve for those that feared a department more aligned with different virtues.
BridgeBio, food and drug administration
Kennedy Jr. are weighing a significant rewrite to the Food and Drug Administration's rules governing food additives, to ...
President-elect Donald Trump has announced several additional Cabinet nominations to positions involving national health, ...
Makary and Weldon, who have criticized the agencies they may soon run, were joined by Janette Nesheiwat, Trump’s pick to be ...
The FDA says America's food supply is still "one of the safest in the world," despite some recent high-profile recalls and ...
Trump, 78, nominated Dr. Marty Makary – a professor at the Johns Hopkins School of Medicine – to serve as FDA commissioner; ...
Florida Gov. Ron DeSantis hailed the Food and Drug Administration’s approval of his plan in January, calling it a victory ...
The U.S. Food and Drug Administration ( FDA) now requires TV and radio drug ads to be clearer and more direct. The new guidelines, which have been over 15 years in the making, are designed to end ...
Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to ...
In one of his most controversial Cabinet picks, President-elect Donald Trump said he would nominate Robert F. Kennedy Jr. to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback